New findings offer improved therapy of early-stage, BRCA mutation-associated breast cancer June 4, 2021
ASCO 2021: HER2CLIMB update shows benefits of adding tucatinib to trastuzumab & capecitabine are maintained in metastatic breast cancer June 4, 2021